Stereotaxis (STXS) Capital Expenditures Growth (1y) (2011 - 2026)
Stereotaxis (STXS) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.65% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -2.04% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 61.83% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -63.39% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 10.63% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 21.73% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.30% |
| 10 | Stereotaxis | 180.48 Mn | 165.86 Mn | 3.79 Mn | 243.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 243.48% |
| Dec 31, 2025 | 3,400.00% |
| Sep 30, 2024 | 0.00% |
| Sep 30, 2023 | -95.12% |
| Jun 30, 2023 | -98.92% |
| Mar 31, 2023 | -69.76% |
| Dec 31, 2022 | -69.15% |
| Sep 30, 2022 | 301.96% |
| Jun 30, 2022 | 460.34% |
| Mar 31, 2022 | 3,294.12% |
| Dec 31, 2019 | 37.53% |
| Sep 30, 2019 | -96.98% |
| Mar 31, 2019 | -1.57% |
| Dec 31, 2018 | 4.56% |
| Sep 30, 2018 | 193.12% |
| Mar 31, 2018 | 132.49% |
| Dec 31, 2015 | 22.43% |
| Sep 30, 2015 | 13.20% |
| Dec 31, 2012 | -98.99% |
| Sep 30, 2012 | -95.22% |